Megan Wind‐Rotolo - Researcher Profile

Publications

1 shown

Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma

Robert J. Motzer , Nizar M. Tannir , Ray McDermott +29 more

Overall survival and objective response rates were significantly higher with nivolumab plus ipilimumab than with sunitinib among intermediate- and poor-risk patients with previo...

2018 New England Journal of Medicine 4403 citations

Frequent Co-Authors

Robert J. Motzer

Memorial Sloan Kettering Cancer Center

Nizar M. Tannir

The University of Texas MD Anderson Cancer Center

Ray McDermott

Researcher Info

h-index: 1
Publications: 1
Citations: 4,403
Institution: Bristol-Myers Squibb (United States)

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0001-8063-9928

Impact Metrics

h-index 1

h-index: Number of publications with at least h citations each.